Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25345009 | 0.88 | ACHE (0.32) | ACHETSHRALDH1A1 | |
| SCHEMBL759928 | 0.88 | EPHX1 (0.37) | ACHEEPHX1 | |
| SCHEMBL760648 | 0.86 | EPHX1 (0.40) | ACHEEPHX1 | |
| SCHEMBL21596988 | 0.84 | EPHX1 (0.43) | ACHEEPHX1 | |
| SCHEMBL25362201 | 0.84 | EPHX1 (0.43) | ACHEEPHX1 | |
| SCHEMBL28915697 | 0.80 | FAAH (0.35) | SMN1; SMN2 | |
| SCHEMBL21016721 | 0.80 | ACHE (0.42) | ACHEMAPK1ALDH1A1EPHX1SMN1; SMN2 | |
| SCHEMBL17660228 | 0.80 | ACHE (0.47) | ACHECHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL13154766 | 0.78 | CHRM2 (0.32) | ACHECHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL3257035 | 0.78 | GAA (0.33) | ACHECHRM2CHRM4CHRM5CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021042890-A1 | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF AS TRK KINASE INHIBITOR | 罗欣药业(上海)有限公司 | 2021-03-11 | — | — | WO | disclosed |
| CN-107428765-B | Pyridazinone macrocyclic compounds used as IRAK inhibitors and uses thereof | 默克专利有限公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-110944664-A | Aziridines containing epothilone analogs, methods of synthesis, methods of treatment, and drug conjugates | 威廉马歇莱思大学 | 2020-03-31 | — | — | CN | disclosed |
| CN-110520413-A | Big ring broad-spectrum antibiotic | RQX PHARMACEUTICALS INC | 2019-11-29 | — | — | CN | disclosed |
| CN-104761507-B | Amido quinazoline derivatives and its application in drug | 广东东阳光药业有限公司 | 2019-11-12 | — | — | CN | disclosed |
| CN-110382478-A | 2,6- Disubstituted pyridine derivatives | 大日本住友制药株式会社 | 2019-10-25 | — | — | CN | disclosed |
| CN-110300751-A | Tetra-substituted alkene compounds and their use for treating breast cancer | 卫材 R&D 管理有限公司 | 2019-10-01 | — | — | CN | disclosed |
| CN-106164072-B | Monocyclic lactam organic compounds for the treatment of bacterial infections | 诺华股份有限公司 | 2019-10-01 | — | — | CN | disclosed |
| CN-110256427-A | 2- (morpholin-4-yl) -1, 7-naphthyridine | 拜耳制药股份公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-110267659-A | Compositions and methods for treating CDK4/6 mediated cancers | 西奈山伊坎医学院 | 2019-09-20 | — | — | CN | disclosed |
| CN-1917873-A | Diurea derivatives | ACTIVE BIOTECH AB (SE) | 2007-02-21 | — | — | CN | disclosed |
| CN-1856305-A | Pyridine derivatives and their use as urotensin II antagonists | ACTELION PHARMACEUTICALS LTD (CH) | 2006-11-01 | — | — | CN | disclosed |
| CN-1838953-A | Phosphatidylinositol 3-kinase (PI3) inhibitor 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives for the treatment of inflammatory airway diseases | NOVARTIS AG (CH) | 2006-09-27 | — | — | CN | disclosed |
| CN-1794988-A | Method for treating vascular hyperpermeable disease | SUCAMPO AG (CH) | 2006-06-28 | — | — | CN | disclosed |
| CN-1784396-A | p38 inhibitors and methods of their use | ARRAY BIOPHARMA INC (US) | 2006-06-07 | — | — | CN | disclosed |
| WO-2005123748-A1 | NOVEL OXABISPIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS | ASTRAZENECA AB (SE) | 2005-12-29 | — | — | WO | disclosed |
| CN-1708476-A | Novel amide compounds having MCH-antagonistic action and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-12-14 | — | — | CN | disclosed |
| CN-1623537-A | Biaryl sulfonamides and its using method | WYETH CORP (US) | 2005-06-08 | — | — | CN | disclosed |
| CN-1617869-A | 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists | ACTELION PHARMACEUTICALS LTD (CH) | 2005-05-18 | — | — | CN | disclosed |
| CN-1344266-A | Novel compounds | ASTRAZENECA AB (SE) | 2002-04-10 | — | — | CN | disclosed |